All News

Patients with acute myeloid leukemia experience post-traumatic stress disorder symptoms including intrusion, avoidance and hypervigilance one month after diagnosis.

A pediatric oncology nurse offers advice for parents or primary caregivers on how to support their child during cancer treatment.

In recent years, research in treating small cell lung cancer has broadened, bringing emerging therapies like immunotherapy to the forefront.

Certain patients with metastatic renal cell carcinoma may benefit with active surveillance compared with systemic therapy for their management and may also lead to an improved quality of life.

Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.

A cancer survivor describes what “chemo fog” is and writes how many people are now experiencing a double whammy — “pandemic fog.”

After the COVID-19 pandemic caused a delay in cancer screenings, an expert from Karmanos Cancer Hospital and Network urges patients to resume their routine preventative care to avoid any delay in a possible diagnosis.

Active surveillance in sentinel lymph node positive melanoma could delay surgery but may result in the same risk of the cancer coming back.

Median progression-free survival in patients treated with Keytruda was 13.2 months versus 8.3 months with Adcetris, which makes Keytruda an “effective treatment option” for patients in this population who were either ineligible for or relapsed after autologous hematopoietic stem cell transplantation.

For the patient with a rare cancer, such as sarcoma, finding hope can be especially problematic, writes a cancer surgeon. Making patients hopeful, he writes, about their medical journey is as important as the medical components of treatment.

Despite on-treatment clinical progression, patients treated with Avastin and standard chemotherapy had a median progression-free survival of 11.8 months compared with 8.8 months in those treated with standard chemotherapy alone.

Inlyta alone demonstrates longer progression-free survival compared to Inlyta in combination with carotuximab.

The month of March has not been kind to this person living with metastatic breast cancer. Here, she recalls what it has been like to become the caregiver with cancer.

Enjoy a refreshing kale salad on a sunny afternoon and a savory chickpea curry during an April shower. And don’t forget to treat yourself with kindness — and pudding!

A wife pens a letter to her husband on the first anniversary of his death from cancer about all the things he’s missed — from the big dates to the boring days, such as just watching TV with their dog.

In an interview with CURE®, Ireland shared details on how to get involved in the "43 challenge" and offered some advice to families who may find themselves impacted by pediatric cancer.

Ayvakit demonstrated more durable survival outcomes in patients with unresectable/metastatic platelet-derived growth factor receptor A D842V-mutant gastrointestinal stromal tumors than tyrosine kinase inhibitors.

How one survivor’s journey led to her realization of what survivorship care is lacking and the importance of advocating for yourself during survivorship.

The FDA has approved the combination of Opdivo (nivolumab) plus certain types of chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction (GEJ) cancer, and esophageal adenocarcinoma, making it the first frontline immunotherapy agent approved in this space.

A cancer survivor and former military service member writes how he used to be short with people, demanded things be done his way and often made others feel little — that is until his cancer diagnosis. Here, he shares how his experience with cancer taught him to be kinder to others.

From a 5-year-old with brain cancer celebrating his final round of radiation at a hockey game to a cancer diagnosis for Exodus drummer Tom Hunting, here’s what’s happening in the cancer landscape this week.

The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.

Lymphoma survivor Nina Luker talks about receiving a diagnosis at age 24 and how sharing her story with nearly 200,000 supporters on social media helped her find purpose.

A recent data review found that dietary patterns such as higher intakes of dietary fiber, calcium and yogurt and lower intakes of red meat and alcohol may lower the risk of colorectal cancer.

Navigating medical leave and insurance forms can be nerve-wracking and feel high stakes for some, writes a cancer survivor. Here, he offers advice on how to manage that stress.

In this episode of the “CURE® Talks Cancer” podcast, Pamela Hegg details her journey with a rare form of endometrial cancer and explains how she’s able to stay positive through multiple recurrences.

Antibiotics, corticosteroids and proton pump inhibitors could cause negative impacts on survival in patients with non-small cell lung cancer who are receiving treatment with Keytruda.

A slower walking pace may be associated with a higher risk of mortality rate in survivors of cancer compared with their healthy matched peers, according to an expert.